title: Statins should be used with greater caution in patients undergoing thyroid hormone withdrawal for radioactive iodine treatment.
authors.forename: Abdallah
authors.initials: A
authors.lastname: Al-Salameh
authors.forename: Hèléne
authors.initials: H
authors.lastname: Bihan
authors.forename: Isabelle
authors.initials: I
authors.lastname: Keller-Petrot
authors.forename: Gérard
authors.initials: G
authors.lastname: Reach
authors.forename: Robin
authors.initials: R
authors.lastname: Dhote
authors.forename: Régis
authors.initials: R
authors.lastname: Cohen
mesh_terms: D003161:Compartment Syndromes / Q000139:chemically induced*; D000075202:Contraindications; D005464:Fluorobenzenes / Q000009:adverse effects*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D009135:Muscular Diseases / Q000139:chemically induced; D011743:Pyrimidines / Q000009:adverse effects*; D000068718:Rosuvastatin Calcium; D013375:Substance Withdrawal Syndrome; D013449:Sulfonamides / Q000009:adverse effects*; D013963:Thyroid Hormones / Q000009:adverse effects*
chemical_list: D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007457:Iodine Radioisotopes; D011743:Pyrimidines; D013449:Sulfonamides; D013963:Thyroid Hormones; D000068718:Rosuvastatin Calcium